TTK Healthcare enterprise value

Share price at each year-end

Tap a line for its trend	Currentlast 12M	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus


1,385	—	—	—	—	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
89.8	21.9	9.0	11.0	9.3
23.9	23.9	24.2	21.5	25.5
1,319	—	—	—	—
−66.0	2.0	15.2	10.5	16.2
₹933.32	—	—	—	—

1,370	1,139	1,089	1,022	979
1.7%	2.1%	2.2%	2.1%	2.6%
0.02×	—	—	—	—

1.44×	—	—	—	—
35.99×	—	—	—	—
47.13×	—	—	—	—
918	857	801	753	725
36.6	26.2	34.8	37.3	31.3
28.0	17.4	26.5	24.3	18.5
—	−21.1	−4.0	−4.9	−26.1
−27.0	−27.0	−16.8	−15.3	−37.8
—	−27.5	−17.7	−16.1	−38.6
—	5.8	12.8	10.4	11.7

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

TTKHLTCARE₹980.00

TTK Healthcare Limited

· Others

₹ CrorePeersDCMSHRIRAM BALMLAWRIE GODREJIND 3MINDIAMcap ₹1,385 Cr

HighlightsEnterprise Value Multiples Per ShareAnnuals · FY-end closes

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Current/LTM TTM · last close
Market Capitalization	—	—	—	—	1,384.8
- Cash, Equiv & ST Investments	9.3	11.0	9.0	21.9	89.8
+ Total Debt	25.5	21.5	24.2	23.9	23.9
Enterprise Value	—	—	—	—	1,318.8
Net Debt (memo)	16.2	10.5	15.2	2.0	-66.0
EV per Share	—	—	—	—	933.32

Total Capital	978.9	1,022.4	1,089.3	1,138.7	1,370.4
Total Debt/Total Capital	2.61	2.10	2.22	2.10	1.74
Total Debt/EV	—	—	—	—	0.02

EV/Sales	—	—	—	—	1.44
EV/EBITDA	—	—	—	—	35.99
EV/EBIT	—	—	—	—	47.13
Reference Items — Trailing FY Values
Sales	725.1	752.8	801.5	857.3	918.2
EBITDA	31.3	37.3	34.8	26.2	36.6
EBIT	18.5	24.3	26.5	17.4	28.0
Operating Cash Flow	-26.1	-4.9	-4.0	-21.1	—
Free Cash Flow	-37.8	-15.3	-16.8	-27.0	-27.0
FCFF (free cash flow to the firm)	-38.6	-16.1	-17.7	-27.5	—
Capital Expenditure	11.7	10.4	12.8	5.8	—

Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.